by Pharmacy Focus: Oncology Edition
In this episode of ASTCT Talks, we're excited to share a special feature from the Pharmacy Focus: Oncology Edition podcast in honor of American Pharmacists Month, featuring members...
by David Porter
In this President’s Message, Dr. David Porter reflects on ASTCT’s 32-year history and his own journey with the society since its founding. He encourages members to renew and invite...
by Rebecca Gonzalez, Pharm.D., BCOP, FASTCT
This spotlight features Rebecca Gonzalez, Pharm.D., BCOP, FASTCT, clinical pharmacy specialist at Moffitt Cancer Center and chair of ASTCT’s Pharmacy Special Interest Group. With a deep...
by Molecular Therapy
Scientists have developed a model to assess the efficacy of mRNA-based chimeric antigen receptor (CAR) T cells, which are understudied despite their potential in treating glioblastoma (GBM) and...
by Blood
Innate lymphoid cells (ILCs) derived from hematopoietic stem cells mitigate graft-versus-host disease (GVHD) in human and mice models but, until now, how they do so has not been fully understood.
by Blood Advances
A real-world study affirmed the safety and efficacy of belumosudil in patients with chronic graft-versus-host disease (cGVHD) while also comparing its performance relative to best available...